Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis.
Androdias G, Noroy L, Psimaras D, Birzu C, Pelletier J, Beigneux Y, Branger P, Ciron J, Dananchet Y, Depaz R, Froment Tilikete C, Gignoux L, Grosset-Janin C, Joubert B, Kerschen P, Kwiatkowski A, Lebrun-Frenay C, Maillart E, Maureille A, Nicolas P, Roux T, Marignier R, Vukusic S; as the ICI-SEP group, under the aegis of the Société Francophone de la Sclérose en Plaques (SFSEP).
Androdias G, et al.
Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200202. doi: 10.1212/NXI.0000000000200202. Epub 2024 Feb 12.
Neurol Neuroimmunol Neuroinflamm. 2024.
PMID: 38346268
Free PMC article.